Technical Analysis for URGN - UroGen Pharma Ltd.

Grade Last Price % Change Price Change
grade D 55.7 0.85% 0.47
URGN closed up 0.85 percent on Tuesday, June 19, 2018, on 1.4 times normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical URGN trend table...

Date Alert Name Type % Chg
Jun 19 Outside Day Range Expansion 0.00%
Jun 18 Oversold Stochastic Weakness 0.85%
Jun 15 NR7 Range Contraction 0.52%
Jun 15 Lower Bollinger Band Walk Weakness 0.52%
Jun 15 Inside Day Range Contraction 0.52%
Jun 15 Oversold Stochastic Weakness 0.52%
Jun 14 Jack-in-the-Box Bearish Bearish Swing Setup 0.29%
Jun 14 Lower Bollinger Band Walk Weakness 0.29%
Jun 14 Inside Day Range Contraction 0.29%
Jun 14 Lower Bollinger Band Touch Weakness 0.29%

Older signals for URGN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
UroGen Pharma Ltd. (UroGen) is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies designed to care for urological pathologies. Its lead product candidates include MitoGel and VesiGel. MiroGel is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC). Its other clinical-stage drug candidate includes Vesimune and BotuGel. Vesimune is a formulation of the toll-like receptor7 (TLR7) agonist Imiquimod for local intravesical delivery for the treatment of Carcinoma In-Situ. BotuGel is an intravesical sustained release formulation of botulinum toxin for Overactive Bladder (OAB) and Interstitial Cystitis (IC). UroGen has developed two platform technologies: RTGel and Immunotherapy.
Is URGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 69.57
52 Week Low 15.56
Average Volume 129,267
200-Day Moving Average 46.0305
50-Day Moving Average 59.1952
20-Day Moving Average 58.648
10-Day Moving Average 56.792
Average True Range 2.5581
ADX 18.79
+DI 12.9
-DI 20.44
Chandelier Exit (Long, 3 ATRs ) 61.8957
Chandelier Exit (Short, 3 ATRs ) 61.3043
Upper Bollinger Band 63.4907
Lower Bollinger Band 53.8053
Percent B (%b) 0.2
BandWidth 16.514459
MACD Line -1.2152
MACD Signal Line -0.6802
MACD Histogram -0.535
Fundamentals Value
Market Cap 724.61 Million
Num Shares 13 Million
EPS -1.67
Price-to-Earnings (P/E) Ratio -33.35
Price-to-Sales 20.42
Price-to-Book 4.84
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 58.97
Resistance 3 (R3) 58.92 57.79 58.43
Resistance 2 (R2) 57.79 56.95 57.81 58.24
Resistance 1 (R1) 56.74 56.44 57.27 56.79 58.06
Pivot Point 55.61 55.61 55.87 55.63 55.61
Support 1 (S1) 54.56 54.77 55.09 54.61 53.34
Support 2 (S2) 53.43 54.26 53.45 53.16
Support 3 (S3) 52.38 53.43 52.98
Support 4 (S4) 52.43